Your session is about to expire
← Back to Search
High-Dose Interferon Alfa for Melanoma
Study Summary
This trial is comparing high dose interferon alfa to observation only in treating patients with stage II or stage III melanoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 2 trial • 116 Patients • NCT00919633Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My skin cancer is at Stage II with a thickness of 1.5-4.0 mm.My skin cancer is confirmed as melanoma.My lymph nodes do not show signs of cancer, either by clinical exam or biopsy.My cancer is stage III with a tumor thicker than 4mm or has spread to one lymph node.
- Group 1: Interferon Alfa-2b
- Group 2: Observation
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In how many places is this study being done?
"There are 100 recruiting patients for this trial such as Marshfield Clinic - Weston Center in Weston, Allan Blair Cancer Centre at Pasqua Hospital in Regina, and Allenmore Hospital in Tacoma. There are also other sites at 100 other locations."
How many people are being given the opportunity to participate in this clinical trial?
"This study has concluded recruitment and is not presently looking for new participants. The trial was posted on December 1st, 1998 and updated June 8th, 2022. There are 786 other trials actively recruiting patients with melanoma and 31 interferon alfa-2b trials currently seeking participants."
What have been documented risks associated with interferon alfa-2b?
"There is pre-existing clinical evidence to support interferon alfa-2b's safety, thus it was given a score of 3."
Are recruitment centers still open for this experiment?
"Unfortunately, this particular trial is no longer looking for patients. The listing was first posted on December 1st, 1998 and updated as recently as June 8th, 2022; however, there are over 800 other trials that do remain open to participants."
Are there other ongoing trials that explore the benefits of interferon alfa-2b?
"31 clinical trials are running to test the efficacy of interferon alfa-2b. 10 of those 31 studies are in Phase 3. Buffalo, New york houses the majority of these studies, but there are 3427 total locations spread out across the world where this research is taking place."
Share this study with friends
Copy Link
Messenger